Pregabalin and Orofacial Neuropathic Pain

Phase 2 Terminated 1 enrolled University of Toronto Pfizer · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether pregabalin can decrease pain and improve quality of life in patients who have nerve pain on the mouth or the face

Timeline

Start: 2009-02
Primary completion: 2010-10
Completion: 2010-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pregabalin	Small molecule	600 mg	Oral

Pregabalin and Orofacial Neuropathic Pain

Summary

Timeline

Drugs

Indications